GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001138995
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 45 positions · Total reported value $5.17B · Top-10 concentration 64.5% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 87.1% · 103 new · 16 cut · 9 exited
Active Share (vs S&P 500): 86.9% · vs QQQ: 85.9% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +1.7% · vs SPY -0.4% · Prev Value $5.23B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +1.8% · vs SPY -0.4% · Latest Value $5.56B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2024 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 45 equity positions with a combined reported value of $5.17B. The filing implies a focused portfolio: its ten largest positions account for 64.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.
The largest disclosed positions as of Q3 2024 were CVS ($751.21M), THC ($441.89M), GPN ($424.14M). By sector, the heaviest allocations are Health Care 28.5%, Consumer Discretionary 21.9%. Versus the prior quarter, allocation shifted toward Technology (+4.9pp), Consumer Staples (+4.5pp) and away from Industrials (-1.2pp), Health Care (-11.9pp).
Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 103 new positions, trimmed 16 and fully exited 9, a turnover rate of 87.1% of positions. The portfolio's overlap with the prior quarter was 72% of names.
The largest new positions opened in Q3 2024 were STX ($44.12M), WDC ($29.66M), DD ($24.55M).
Of the 9 positions fully exited versus the prior quarter, the largest were CNC ($94.90M), HCA ($62.84M), ELV ($53.42M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- STX SEAGATE TECHNOLOGY HLDNGS PL · $44.12M
- WDC WESTERN DIGITAL CORP · $29.66M
- DD DUPONT DE NEMOURS INC · $24.55M
- SEE SEALED AIR CORP NEW COM · $24.49M
- HSIC SCHEIN HENRY INC · $12.73M
- HTZ HERTZ GLOBAL HLDGS INC · $1.45M
Fully Exited (vs previous quarter)
- CNC CENTENE CORP DEL · prev qtr: $94.90M · history
- HCA HCA HEALTHCARE INC · prev qtr: $62.84M
- ELV ELEVANCE HEALTH INC FORMERLY · prev qtr: $53.42M
- EXAS EXACT SCIENCES CORP COM · prev qtr: $26.59M
- VVV VALVOLINE INC · prev qtr: $20.91M
- CRS CARPENTER TECHNOLOGY CORP · prev qtr: $14.25M
- BHC BAUSCH HEALTH COS INC · prev qtr: $9.11M
- FISV FISERV INC · prev qtr: $8.01M
Insider Transactions (Form 4)
Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 138 US equity positions with a combined value of $5.56B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-73695 (status: Approved), registered 2012-03-30
- Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 6 private funds, of which 6 hedge funds
Portfolio Structure
- 138 positions · $5.56B reported value (Q3 2026)
- Top 10 holdings = 58.3% of reported value
- Largest position: GPN (GLOBAL PMTS INC) at 10.4%
- Average position size: $40.30M
Sector Tilt
- Health Care 27.8%
- Consumer Discretionary 24.5%
- Industrials 21.7%
- (classified holdings cover 92% of value)
Quarterly Activity
- Q3 2026: 103 new, 16 added, 16 reduced, 9 exited
- 3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
11.95M | $751.21M | 14.54% | Add | |
| 2 |
|
2.66M | $441.89M | 8.55% | Reduce | |
| 3 |
|
4.14M | $424.14M | 8.21% | Add | |
| 4 |
|
1.05M | $364.34M | 7.05% | Reduce | |
| 5 |
|
5.24M | $308.24M | 5.97% | Add | |
| 6 |
|
1.34M | $295.64M | 5.72% | Add | |
| 7 |
|
11.17M | $231.86M | 4.49% | Add | |
| 8 |
|
26.24M | $186.34M | 3.61% | Add | |
| 9 |
|
733.26K | $167.92M | 3.25% | Reduce | |
| 10 |
|
1.09M | $161.45M | 3.12% | Add | |
| 11 |
|
8.46M | $152.38M | 2.95% | Reduce | |
| 12 |
|
232.90K | $133.63M | 2.59% | Hold | |
| 13 |
|
266.94K | $131.98M | 2.55% | Hold | |
| 14 |
|
17.71M | $131.07M | 2.54% | Reduce | |
| 15 |
|
4.51M | $122.42M | 2.37% | Reduce | |
| 16 |
|
1.81M | $111.53M | 2.16% | Reduce | |
| 17 |
|
9.56M | $110.00M | 2.13% | Add | |
| 18 |
|
475.43K | $88.59M | 1.72% | Add | |
| 19 |
|
7.57M | $87.91M | 1.70% | Add | |
| 20 |
|
1.17M | $84.03M | 1.63% | Add | |
| 21 |
|
1.53M | $82.29M | 1.59% | Add | |
| 22 |
|
1.05M | $78.68M | 1.52% | Reduce | |
| 23 |
|
666.93K | $58.42M | 1.13% | Add | |
| 24 |
|
274.79K | $46.16M | 0.89% | Reduce | |
| 25 |
|
402.77K | $44.12M | 0.85% | New | |
| 26 |
|
1.15M | $43.42M | 0.84% | Add | |
| 27 |
|
165.13K | $40.84M | 0.79% | Add | |
| 28 |
|
3.94M | $40.61M | 0.79% | Add | |
| 29 |
|
1.26M | $34.55M | 0.67% | Reduce | |
| 30 |
|
434.28K | $29.66M | 0.57% | New | |
| 31 |
|
275.49K | $24.55M | 0.47% | New | |
| 32 |
|
674.66K | $24.49M | 0.47% | New | |
| 33 |
|
284.79K | $23.87M | 0.46% | Reduce | |
| 34 |
|
4.89M | $19.81M | 0.38% | Reduce | |
| 35 |
|
174.31K | $19.09M | 0.37% | Reduce | |
| 36 |
|
9.96M | $17.62M | 0.34% | Add | |
| 37 |
|
2.50M | $16.98M | 0.33% | Reduce | |
| 38 |
|
174.66K | $12.73M | 0.25% | New | |
| 39 |
|
789.39K | $10.06M | 0.20% | Reduce | |
| 40 |
|
199.25K | $5.36M | 0.10% | Reduce | |
| 41 |
|
475.00K | $3.87M | 0.07% | Reduce | |
| 42 |
|
439.25K | $1.45M | 0.03% | New | |
| 43 |
|
63.20K | $987.12K | 0.02% | Reduce | |
| 44 |
|
547.99K | $487.71K | 0.01% | Reduce | |
| 45 |
|
1.71M | $140.49K | 0.00% | Hold | |
FAQ
What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 45 equity positions worth $5.17B in aggregate; its largest disclosed positions were CVS ($751.21M), THC ($441.89M), GPN ($424.14M).
How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?
GLENVIEW CAPITAL MANAGEMENT, LLC reported $5.17B of long equity holdings across 45 positions as of 2024-Q3. Top-10 holdings account for 64.5% of reported value.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.